- Home
- JTAI vs ICU Comparison
JTAI vs ICU Comparison
Compare JTAI & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JTAI
- ICU
- Stock Information
- Founded
- JTAI 2018
- ICU 2018
- Country
- JTAI United States
- ICU United States
- Employees
- JTAI N/A
- ICU N/A
- Industry
- JTAI Blank Checks
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- JTAI Finance
- ICU Health Care
- Exchange
- JTAI Nasdaq
- ICU Nasdaq
- Market Cap
- JTAI 9.9M
- ICU 10.4M
- IPO Year
- JTAI N/A
- ICU N/A
- Fundamental
- Price
- JTAI $3.70
- ICU $0.61
- Analyst Decision
- JTAI
- ICU
- Analyst Count
- JTAI 0
- ICU 0
- Target Price
- JTAI N/A
- ICU N/A
- AVG Volume (30 Days)
- JTAI 208.7K
- ICU 19.2M
- Earning Date
- JTAI 08-13-2025
- ICU 08-12-2025
- Dividend Yield
- JTAI N/A
- ICU N/A
- EPS Growth
- JTAI N/A
- ICU N/A
- EPS
- JTAI N/A
- ICU N/A
- Revenue
- JTAI $13,648,668.00
- ICU $428,000.00
- Revenue This Year
- JTAI $13.37
- ICU $754.07
- Revenue Next Year
- JTAI $201.13
- ICU $100.09
- P/E Ratio
- JTAI N/A
- ICU N/A
- Revenue Growth
- JTAI N/A
- ICU N/A
- 52 Week Low
- JTAI $2.30
- ICU $0.31
- 52 Week High
- JTAI $97.40
- ICU $9.56
- Technical
- Relative Strength Index (RSI)
- JTAI 49.53
- ICU 41.48
- Support Level
- JTAI $3.33
- ICU $0.52
- Resistance Level
- JTAI $3.75
- ICU $0.83
- Average True Range (ATR)
- JTAI 0.21
- ICU 0.16
- MACD
- JTAI 0.03
- ICU 0.04
- Stochastic Oscillator
- JTAI 59.68
- ICU 50.89
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.